BioCentury | Nov 27, 2019
Company News
Nov. 27 Company Quick Takes: Orexo, GAIA in second deal for substance abuse digital therapy; plus PDUFA date for Verrica's skin infection candidate and $25M fol
...companies to develop a psychosocial support product intended to enhance the use of Orexo's Zubsolv buprenorphine/naloxone...